BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 20159951)

  • 21. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
    Kim M; Murakami A; Kawabata K; Ohigashi H
    Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
    Nakazato T; Ito K; Ikeda Y; Kizaki M
    Clin Cancer Res; 2005 Aug; 11(16):6040-9. PubMed ID: 16115949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGCG regulates CTR1 expression through its pro-oxidative property in non-small-cell lung cancer cells.
    Chen A; Jiang P; Zeb F; Wu X; Xu C; Chen L; Feng Q
    J Cell Physiol; 2020 Nov; 235(11):7970-7981. PubMed ID: 31943177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model.
    Sartor L; Pezzato E; Donà M; Dell'Aica I; Calabrese F; Morini M; Albini A; Garbisa S
    Int J Cancer; 2004 Dec; 112(5):823-9. PubMed ID: 15386368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
    Lee MH; Han DW; Hyon SH; Park JC
    Apoptosis; 2011 Jan; 16(1):75-85. PubMed ID: 20963498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
    Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (-)-Epigallocatechin gallate causes oxidative damage to isolated and cellular DNA.
    Furukawa A; Oikawa S; Murata M; Hiraku Y; Kawanishi S
    Biochem Pharmacol; 2003 Nov; 66(9):1769-78. PubMed ID: 14563487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
    Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
    Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
    Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
    Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models.
    Wei R; Mao L; Xu P; Zheng X; Hackman RM; Mackenzie GG; Wang Y
    Food Funct; 2018 Nov; 9(11):5682-5696. PubMed ID: 30310905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigallocatechin-3-gallate attenuates acrylamide-induced apoptosis and astrogliosis in rat cerebral cortex.
    He Y; Tan D; Bai B; Wu Z; Ji S
    Toxicol Mech Methods; 2017 May; 27(4):298-306. PubMed ID: 28056603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth
    Amin ARMR; Wang D; Nannapaneni S; Lamichhane R; Chen ZG; Shin DM
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33864659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigallocatechin gallate protects against oxidative stress-induced mitochondria-dependent apoptosis in human lens epithelial cells.
    Yao K; Ye P; Zhang L; Tan J; Tang X; Zhang Y
    Mol Vis; 2008 Jan; 14():217-23. PubMed ID: 18334937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants.
    Xu Y; Ho CT; Amin SG; Han C; Chung FL
    Cancer Res; 1992 Jul; 52(14):3875-9. PubMed ID: 1617663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro.
    Wu F; Sun H; Kluz T; Clancy HA; Kiok K; Costa M
    Toxicol Appl Pharmacol; 2012 Jan; 258(2):166-75. PubMed ID: 22079256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticancer effects of epigallocatechin-3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway.
    Chen BH; Hsieh CH; Tsai SY; Wang CY; Wang CC
    Sci Rep; 2020 Mar; 10(1):5163. PubMed ID: 32198390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prooxidative effects of green tea polyphenol (-)-epigallocatechin-3-gallate on the HIT-T15 pancreatic beta cell line.
    Suh KS; Chon S; Oh S; Kim SW; Kim JW; Kim YS; Woo JT
    Cell Biol Toxicol; 2010 Jun; 26(3):189-99. PubMed ID: 19757103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (-)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice.
    Yao YF; Liu X; Li WJ; Shi ZW; Yan YX; Wang LF; Chen M; Xie MY
    Life Sci; 2017 Jul; 180():151-159. PubMed ID: 27956351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of beta-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations.
    Dashwood WM; Orner GA; Dashwood RH
    Biochem Biophys Res Commun; 2002 Aug; 296(3):584-8. PubMed ID: 12176021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Epigallocatechin-3-gallate on lead-induced oxidative damage.
    Yin ST; Tang ML; Su L; Chen L; Hu P; Wang HL; Wang M; Ruan DY
    Toxicology; 2008 Jul; 249(1):45-54. PubMed ID: 18499326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.